Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum

British Journal of Haematology

Volumn 115, Issue 4, 2001, Pages 918-923

  Goudeau, Carmen ^a   Loyevsky, Mark ^a,c   Kassim, Olakunle O ^a   Gordeuk, Victor R ^a   Nick, Hanspeter ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c HOWARD UNIVERSITY   (United States)

Author keywords

ICL670A; Iron chelators; Malaria; Plasmodium falciparum

Indexed keywords

4 [[3,5 BIS(2 HYDROXYPHENYL) 1,2,4]TRIAZOL 1 YL]BENZOIC ACID; DEFERASIROX; DEFEROXAMINE; HYPOXANTHINE; IRON; IRON CHELATE; TRITIUM; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IRON OVERLOAD; NONHUMAN; PARASITE CULTIVATION; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMALARIALS; BENZOIC ACIDS; CELLS, CULTURED; CHELATING AGENTS; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HYPOXANTHINE; PLASMODIUM FALCIPARUM; TRIAZOLES;

EID: 0035676178     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03159.x     Document Type: Article

References (20)

1. Iron chelators as antimalarials: The biochemical basis of selective cytotoxicity
2. Iron chelators: Mode of action as antimalarials
3. Recent trends in the epidemiology and control of malaria
4. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells
5. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia
6. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria
7. 4-[(3,5-Bis-(2-hydroxyphenyl)-1,2,4) triazol-1-yl]-benzoic acid: A novel efficient and selective iron (III) complexing agent
8. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxyppyridin-4-one oral iron chelators
9. Co-administration of desferrioxamine B with artesunate in malaria: An assessment of safety and tolerance
10. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites
11. Mode of action of iron (III) chelators as antimalarials. I: Membrane permeation properties and cytotoxic activity
12. Artemisinin antimalarials: Mechanisms of action and resistance
13. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators
14. 59Fe in plasmodium falciparum in the presence of oxines
15. Reversed siderophores act as anti-malarial agents
16. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans
17. Continuous culture of human malaria parasites
18. Antimalarial effect of HBED and other phenolic and catecholic iron chelators